There were 45 press releases posted in the last 24 hours and 193,603 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Personalized Stem Cells Announces Enrollment Complete for COVID-19 Clinical Trial Licensed to Sorrento Therapeutics

TO:
Michael Dale, President/COO
Personalized Stem Cells, Inc
+1 833-772-3557

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image